ATE245448T1 - Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten - Google Patents

Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten

Info

Publication number
ATE245448T1
ATE245448T1 AT97900169T AT97900169T ATE245448T1 AT E245448 T1 ATE245448 T1 AT E245448T1 AT 97900169 T AT97900169 T AT 97900169T AT 97900169 T AT97900169 T AT 97900169T AT E245448 T1 ATE245448 T1 AT E245448T1
Authority
AT
Austria
Prior art keywords
compositions
cell death
influx
influx blocker
agent
Prior art date
Application number
AT97900169T
Other languages
English (en)
Inventor
Stuart Alan Berger
Jennifer Lynn Gommerman
Original Assignee
Wellesley Hospital Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellesley Hospital Found filed Critical Wellesley Hospital Found
Application granted granted Critical
Publication of ATE245448T1 publication Critical patent/ATE245448T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97900169T 1996-01-11 1997-01-13 Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten ATE245448T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58400096A 1996-01-11 1996-01-11
PCT/CA1997/000019 WO1997025063A1 (en) 1996-01-11 1997-01-13 Compositions including calcium influx blockers for inhibiting cell growth

Publications (1)

Publication Number Publication Date
ATE245448T1 true ATE245448T1 (de) 2003-08-15

Family

ID=24335483

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97900169T ATE245448T1 (de) 1996-01-11 1997-01-13 Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten

Country Status (13)

Country Link
EP (1) EP0873137B1 (de)
JP (1) JP2000513708A (de)
KR (1) KR19990077183A (de)
CN (1) CN1099296C (de)
AT (1) ATE245448T1 (de)
AU (1) AU732012B2 (de)
BR (1) BR9710942A (de)
CA (1) CA2242866A1 (de)
DE (1) DE69723670D1 (de)
IL (1) IL125297A0 (de)
PL (1) PL327921A1 (de)
TR (1) TR199801359T2 (de)
WO (1) WO1997025063A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000054332A (ko) * 2000-06-01 2000-09-05 김진경 혈관내피세포 성장인자 억제제에 의한 암 치료법
WO2004013629A2 (en) * 2002-07-29 2004-02-12 Novartis Ag Screening for agents suitable for treatment of leukocyte associated inflammatory diseases
KR100573881B1 (ko) * 2003-11-29 2006-04-26 장양수 허혈증상 치료제
CN104324039A (zh) * 2014-10-20 2015-02-04 付茜 一种治疗人身体表面脂肪瘤的药剂及使用方法
CN110106146B (zh) * 2019-03-28 2021-04-02 中国人民解放军军事科学院军事医学研究院 化合物富马酸酮替芬在促进干细胞因子合成和分泌中的用途
CN113384551B (zh) * 2021-05-07 2022-03-08 西安交通大学 一种减少肿瘤内过量钙离子的仿生纳米载体的制备方法和应用

Also Published As

Publication number Publication date
CA2242866A1 (en) 1997-07-17
BR9710942A (pt) 2000-10-24
CN1213315A (zh) 1999-04-07
KR19990077183A (ko) 1999-10-25
PL327921A1 (en) 1999-01-04
WO1997025063A1 (en) 1997-07-17
EP0873137B1 (de) 2003-07-23
JP2000513708A (ja) 2000-10-17
IL125297A0 (en) 1999-03-12
DE69723670D1 (de) 2003-08-28
CN1099296C (zh) 2003-01-22
AU1362897A (en) 1997-08-01
TR199801359T2 (xx) 1998-10-21
AU732012B2 (en) 2001-04-12
EP0873137A1 (de) 1998-10-28

Similar Documents

Publication Publication Date Title
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
NO921875D0 (no) Metallpeptidpreparater og fremgangsmaater for aa stimulere haarvekst
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
MY104535A (en) Oral composition for the treatment of inflammatory bowel diseases.
ATE219674T1 (de) Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
PE30891A1 (es) Composiciones y metodos terapeuticos sinergicos
AR024516A1 (es) Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica.
ATE364699T1 (de) Humanisierte antikörper gegen humanes gp39, zusammensetzungen die diese enthalten und deren therapeutische verwendungen
DE69430440D1 (de) Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DE69332713D1 (de) Verwendung von Histamine-2 Agonisten zur Behandlung sexueller Funktionsstörungen
ATE227717T1 (de) 3-pyridylenantiomere und ihre verwendung als analgetika
ATE135208T1 (de) Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
DE60033649D1 (de) Verbindungen und therapeutische methoden
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
ATE240725T1 (de) Mittel zur behandlung lichtgeschädigter haut die einen rar-alpha antagonisten und ein multiselektives retinoid enthalten
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
ATE245448T1 (de) Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
BR9911756A (pt) Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto
ATE222768T1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties